Showing results (41-50 of 93) with videos related to

Sort By:
Pageof 10
Expert Opinion on Biological Therapy|April 8, 2014
Ipilimumab in non-small cell lung cancer and small-cell lung cancer: new knowledge on a new therapeutic strategyErika Rijavec, Carlo Genova, Giulia Barletta, et al.
Expert Opinion on Pharmacotherapy|July 18, 2014
Efficacy of motesanib diphosphate in non-small-cell lung cancerErika Rijavec, Carlo Genova, Giulia Barletta, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 12, 2021
Total neoadjuvant therapy for initially inoperable pancreatic cancer: A systematic review of phase 2-3 studiesGianluca Tomasello, Michele Ghidini, Antonio Ghidini, et al.
Anti-Cancer Agents in Medicinal Chemistry|February 5, 2016
Fibroblast Growth Factor Receptor (FGFR): A New Target for Non-small Cell Lung Cancer TherapyFederica Biello, Giovanni Burrafato, Erika Rijavec, et al.
International Journal of Molecular Sciences|November 6, 2019
Targeting Immune-Related Biological Processes in Solid Tumors: We do Need BiomarkersFabio Pagni, Elena Guerini-Rocco, Anne Maria Schultheis, et al.
Expert Opinion on Pharmacotherapy|May 21, 2013
Pemetrexed for the treatment of non-small cell lung cancerCarlo Genova, Erika Rijavec, Anna Truini, et al.
Expert Opinion on Investigational Drugs|April 8, 2017
Investigational drugs targeting fibroblast growth factor receptor in the treatment of non-small cell lung cancerErika Rijavec, Carlo Genova, Giulia Barletta, et al.
Future Oncology (London, England)|December 17, 2013
Role of immunotherapy in the treatment of advanced non-small-cell lung cancerErika Rijavec, Carlo Genova, Angela Alama, et al.
Microrna (Shariqah, United Arab Emirates)|January 29, 2016
Prognostic and Therapeutic Implications of MicroRNA in Malignant Pleural MesotheliomaAnna Truini, Simona Coco, Carlo Genova, et al.
Vaccines|May 28, 2022
Renal Function Outcomes in Metastatic Non-Small-Cell Lung Carcinoma Patients Treated with Chemotherapy or Immune Checkpoint Inhibitors: An Unexpected ScenarioFrancesco Trevisani, Federico Di Marco, Matteo Floris, et al.
Pageof 10